Sign Up Today and Learn More About DiogenX Stock
Invest in or calculate the value of your shares in DiogenX or other pre-IPO companies through EquityZen's platform.
DiogenX Stock (DIOX)
DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.
About DiogenX Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
DiogenX Press Mentions
Stay in the know about the latest news on DiogenX
DiogenX appoints Dr. Klara Owen as Chief Medical Officer
pharmiweb • Nov 12, 2024
MaddyMoney : 148,7 millions d'euros levés cette semaine par ...
maddyness • Dec 25, 2023
Six diabetes biotech companies looking beyond insulin
labiotech • Dec 25, 2023
DiogenX–Juvenile Diabetes Research Foundation: investment, 202305 financing round Series A totalling €27.5m incl existing + co-investor JDRF T1D Fund
life-sciences-europe • May 14, 2023
DiogenX raises €27.5M for “breakthrough” diabetes treatment
labiotech • May 13, 2023
DiogenX Management
Leadership team at DiogenX
Board Member
Johannes Zanzinger
Board Member
David Evans
Join now and verify your accreditation status to gain access to:
- DiogenX current valuation
- DiogenX stock price
- Available deals in DiogenX and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in DiogenX stock?
Accredited investors can buy pre-IPO stock in companies like DiogenX through EquityZen funds. These investments are made available by existing DiogenX shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell DiogenX stock?
Shareholders can sell their DiogenX stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
